The Combination of Stereotactic Body Radiation Therapy and Immunotherapy in Primary Liver Tumors.
Journal
Journal of oncology
ISSN: 1687-8450
Titre abrégé: J Oncol
Pays: Egypt
ID NLM: 101496537
Informations de publication
Date de publication:
2019
2019
Historique:
received:
28
12
2018
revised:
18
03
2019
accepted:
25
03
2019
entrez:
12
6
2019
pubmed:
12
6
2019
medline:
12
6
2019
Statut:
epublish
Résumé
Treatment recommendations for primary liver malignancies, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), are complex and require a multidisciplinary approach. Despite surgical options that are potentially curative, options for nonsurgical candidates include systemic therapy, radiotherapy (RT), transarterial chemoembolization (TACE), and radiofrequency ablation (RFA). Stereotactic Body Radiation Therapy (SBRT) is now in routine use for the treatment of lung cancer, and there is growing evidence supporting its use in liver tumors. SBRT has the advantage of delivering ablative radiation doses in a limited number of fractions while minimizing the risk of radiation-induced liver disease (RILD) through highly conformal treatment plans. It should be considered in a multidisciplinary setting for the management of patients with unresectable, locally advanced primary liver malignancies and limited treatment options. Recently, the combination of immunotherapy with SBRT has been proposed to improve antitumor effects through engaging the immune system. This review aims at shedding light on the novel concept of the combination strategy of immune-radiotherapy in liver tumors by exploring the evidence surrounding the use of SBRT and immunotherapy for the treatment of HCC and CCA.
Identifiants
pubmed: 31182960
doi: 10.1155/2019/4304817
pmc: PMC6512065
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
4304817Références
Int J Oncol. 1999 Oct;15(4):769-73
pubmed: 10493960
Gut. 2001 Jun;48(6):816-20
pubmed: 11358902
Hepatology. 2001 Jun;33(6):1353-7
pubmed: 11391522
Immunity. 2002 Aug;17(2):201-10
pubmed: 12196291
Hepatology. 2003 Feb;37(2):429-42
pubmed: 12540794
Hepatology. 2003 May;37(5):961-9
pubmed: 12717374
Br J Radiol. 1953 May;26(305):234-41
pubmed: 13042090
Oncologist. 2004;9(1):43-57
pubmed: 14755014
Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):862-70
pubmed: 14967443
Semin Liver Dis. 2004 May;24(2):115-25
pubmed: 15192785
Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):728-34
pubmed: 15701862
Am J Surg. 2005 Feb;189(2):173-7
pubmed: 15720985
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
pubmed: 15761078
Cancer Treat Rev. 2005 May;31(3):159-72
pubmed: 15923088
J Immunol. 2005 Jun 15;174(12):7516-23
pubmed: 15944250
Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):655-66
pubmed: 16199306
J Clin Oncol. 2005 Dec 1;23(34):8739-47
pubmed: 16314634
Nat Rev Cancer. 2005 Nov;5(11):867-75
pubmed: 16327765
Eur J Immunol. 2006 Jun;36(6):1413-22
pubmed: 16708397
Cell. 2006 Jul 28;126(2):375-87
pubmed: 16873067
Science. 2006 Sep 29;313(5795):1972-5
pubmed: 16931720
Acta Oncol. 2006;45(7):848-55
pubmed: 16982549
Nature. 2007 Feb 15;445(7129):771-5
pubmed: 17220874
Gastroenterology. 2007 Jun;132(7):2557-76
pubmed: 17570226
Immunity. 2007 Jul;27(1):111-22
pubmed: 17629517
Nat Med. 2007 Sep;13(9):1050-9
pubmed: 17704786
Radiother Oncol. 2007 Oct;85(1):7-16
pubmed: 17920715
J Clin Oncol. 2008 Feb 1;26(4):657-64
pubmed: 18172187
Ann Surg. 2008 Jul;248(1):84-96
pubmed: 18580211
Cell. 2008 Aug 22;134(4):587-98
pubmed: 18724932
Science. 2008 Nov 14;322(5904):1097-100
pubmed: 19008445
World J Gastroenterol. 2008 Nov 7;14(41):6289-97
pubmed: 19009641
Ann Surg Oncol. 2009 Feb;16(2):404-12
pubmed: 19037702
J Clin Oncol. 2009 Mar 20;27(9):1485-91
pubmed: 19224838
Blood. 2009 May 7;113(19):4556-65
pubmed: 19246340
Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):677-82
pubmed: 19251380
J Clin Oncol. 2009 Apr 1;27(10):1585-91
pubmed: 19255313
Blood. 2009 Jul 16;114(3):589-95
pubmed: 19349616
Clin Cancer Res. 2009 Sep 1;15(17):5379-88
pubmed: 19706802
J Exp Med. 2009 Dec 21;206(13):3015-29
pubmed: 20008522
Am J Clin Pathol. 2010 Apr;133(4):646-53
pubmed: 20231618
Int J Cancer. 2011 Feb 15;128(4):887-96
pubmed: 20473887
Hepatology. 2010 Aug;52(2):762-73
pubmed: 20564355
J Hepatol. 2011 Apr;54(4):830-4
pubmed: 21145836
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
pubmed: 21296855
Cancer Res. 2011 Apr 1;71(7):2488-96
pubmed: 21300764
J Clin Oncol. 2011 Aug 10;29(23):3140-5
pubmed: 21730269
Anticancer Res. 2011 Jun;31(6):2291-5
pubmed: 21737654
J Exp Med. 2011 Sep 26;208(10):2005-16
pubmed: 21930765
J Exp Med. 2011 Sep 26;208(10):1989-2003
pubmed: 21930769
Semin Radiat Oncol. 2011 Oct;21(4):241-6
pubmed: 21939852
Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1306-10
pubmed: 22208977
Annu Rev Immunol. 2012;30:677-706
pubmed: 22224761
World J Gastroenterol. 2012 Feb 14;18(6):498-506
pubmed: 22363115
N Engl J Med. 2012 Mar 8;366(10):925-31
pubmed: 22397654
J Hepatol. 2012 Apr;56(4):908-43
pubmed: 22424438
Radiat Oncol. 2012 May 03;7:67
pubmed: 22553982
Front Oncol. 2012 Aug 07;2:88
pubmed: 22891162
J Clin Invest. 2012 Nov;122(11):4094-104
pubmed: 23064360
Front Oncol. 2012 Oct 26;2:153
pubmed: 23112958
J Registry Manag. 2011 Winter;38(4):201-5
pubmed: 23270094
Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):343-9
pubmed: 23462419
J Hepatol. 2013 Jul;59(1):81-8
pubmed: 23466307
Immunity. 2013 Mar 21;38(3):541-54
pubmed: 23477736
J Clin Oncol. 2013 May 1;31(13):1631-9
pubmed: 23547075
N Engl J Med. 2013 Jul 11;369(2):134-44
pubmed: 23724846
Acta Oncol. 2014 Mar;53(3):399-404
pubmed: 23962244
Cancer Lett. 2015 Jan 1;356(1):82-90
pubmed: 24125863
Transl Oncol. 2013 Oct 01;6(5):511-9
pubmed: 24151531
Biomed Res Int. 2013;2013:658126
pubmed: 24324970
J Clin Invest. 2014 Feb;124(2):687-95
pubmed: 24382348
Surg Oncol Clin N Am. 2014 Apr;23(2):353-68
pubmed: 24560114
Cancer Immunol Res. 2013 Dec;1(6):365-72
pubmed: 24563870
Lancet Oncol. 2014 Jun;15(7):700-12
pubmed: 24831977
Radiat Res. 2014 Aug;182(2):191-200
pubmed: 24972258
J Clin Oncol. 2014 Sep 20;32(27):2959-66
pubmed: 25071121
HPB (Oxford). 2015 Feb;17(2):140-9
pubmed: 25186290
Cancer Immunol Res. 2014 Sep;2(9):831-8
pubmed: 25187273
Cancer Res. 2014 Oct 1;74(19):5458-68
pubmed: 25274032
Front Oncol. 2014 Nov 28;4:325
pubmed: 25506582
Cancer Immunol Res. 2015 Jun;3(6):610-9
pubmed: 25701325
Nature. 2015 Apr 16;520(7547):373-7
pubmed: 25754329
Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):390-8
pubmed: 25754628
Cancer Res. 2015 Jun 1;75(11):2232-42
pubmed: 25858148
Lancet Oncol. 2015 Jun;16(6):630-7
pubmed: 25981812
Adv Immunol. 2015;127:1-31
pubmed: 26073982
Lancet Oncol. 2015 Jul;16(7):795-803
pubmed: 26095785
Nat Genet. 2015 Sep;47(9):1003-10
pubmed: 26258846
Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):16-25
pubmed: 26279020
World J Gastroenterol. 2015 Sep 28;21(36):10314-26
pubmed: 26420958
Cancer Discov. 2016 Jan;6(1):71-9
pubmed: 26493961
J Clin Oncol. 2016 Feb 10;34(5):452-9
pubmed: 26628466
J Clin Oncol. 2016 Feb 10;34(5):460-8
pubmed: 26668346
Int J Clin Exp Med. 2015 Nov 15;8(11):20988-1000
pubmed: 26885030
Cancer. 2016 Jul 1;122(13):1974-86
pubmed: 26950735
Oncologist. 2016 May;21(5):594-9
pubmed: 27000463
Int J Cancer. 2016 Oct 1;139(7):1534-45
pubmed: 27244487
Oncotarget. 2016 Sep 13;7(37):59820-59833
pubmed: 27486977
Clin Cancer Res. 2017 Mar 15;23(6):1388-1396
pubmed: 27649551
Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):578-88
pubmed: 27681753
Trends Cancer. 2016 Jun;2(6):286-294
pubmed: 27774519
Cancer Res. 2017 Feb 15;77(4):839-850
pubmed: 27821490
Oncotarget. 2017 Feb 28;8(9):16052-16074
pubmed: 28030802
Nat Rev Clin Oncol. 2017 Jun;14(6):365-379
pubmed: 28094262
Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):1637-1642
pubmed: 28137885
Oncology. 2017;92 Suppl 1:50-62
pubmed: 28147363
J Hepatol. 2017 Aug;67(2):302-309
pubmed: 28336466
Histopathology. 2017 Sep;71(3):383-392
pubmed: 28419539
Lancet Oncol. 2017 Jul;18(7):e371
pubmed: 28552211
Nat Commun. 2017 Jun 09;8:15618
pubmed: 28598415
Clin Cancer Res. 2018 Jan 15;24(2):259-265
pubmed: 28751442
Oncoimmunology. 2017 Jun 16;6(9):e1339857
pubmed: 28932642
Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):122-130
pubmed: 29066120
Mod Pathol. 2018 Feb;31(2):214-234
pubmed: 29192647
Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):677-679
pubmed: 29280462
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
J Thorac Oncol. 2018 Apr;13(4):550-558
pubmed: 29378267
J Clin Oncol. 2018 Jun 1;36(16):1611-1618
pubmed: 29437535
Oncotarget. 2018 May 4;9(34):23366-23372
pubmed: 29805739
Ann Oncol. 2018 Aug 1;29(8):1630-1632
pubmed: 30052725
Expert Opin Investig Drugs. 2018 Sep;27(9):709-720
pubmed: 30124336
J Thorac Dis. 2018 Aug;10(Suppl 21):S2492-S2507
pubmed: 30206494
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Gastrointest Oncol. 2018 Dec;9(6):1014-1026
pubmed: 30603120
Acta Oncol. 1995;34(6):861-70
pubmed: 7576756